From the standpoint of identifying the roots mistrust in biopharma, a study by Deloitte describe the industry as being profit-driven, harmful and designed to create dependency. The above statement can be analyzed through various perspectives, as the findings uncover the key factors eroding trust in pharmaceutical companies worldwide. In health technology, trust could be the essential ingredient that turns innovation into “real-world change”.